Indian court rejects AstraZeneca’s injunction request
24-11-2020
Daiichi and AstraZeneca fight back in cancer drug dispute with Seagen
18-11-2020
Roland Magnusson / Shutterstock.com
AstraZeneca has announced it will acquire Boston-based biopharmaceutical company Alexion Pharmaceuticals, in what is potentially the biggest life sciences deal of this year.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
AstraZeneca, Alexion, biopharma, mergers and acquisitions, M&A, immunology,
